- Home
- DCTH vs IFN Comparison
DCTH vs IFN Comparison
Compare DCTH & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- IFN
- Stock Information
- Founded
- DCTH 1988
- IFN 1993
- Country
- DCTH United States
- IFN Singapore
- Employees
- DCTH N/A
- IFN N/A
- Industry
- DCTH Medical/Dental Instruments
- IFN Finance/Investors Services
- Sector
- DCTH Health Care
- IFN Finance
- Exchange
- DCTH Nasdaq
- IFN Nasdaq
- Market Cap
- DCTH 518.0M
- IFN 598.1M
- IPO Year
- DCTH N/A
- IFN N/A
- Fundamental
- Price
- DCTH $14.88
- IFN $15.28
- Analyst Decision
- DCTH Strong Buy
- IFN
- Analyst Count
- DCTH 4
- IFN 0
- Target Price
- DCTH $22.25
- IFN N/A
- AVG Volume (30 Days)
- DCTH 356.0K
- IFN 135.2K
- Earning Date
- DCTH 03-06-2025
- IFN 01-01-0001
- Dividend Yield
- DCTH N/A
- IFN 8.68%
- EPS Growth
- DCTH N/A
- IFN N/A
- EPS
- DCTH N/A
- IFN N/A
- Revenue
- DCTH $22,644,000.00
- IFN N/A
- Revenue This Year
- DCTH $1,672.40
- IFN N/A
- Revenue Next Year
- DCTH $116.33
- IFN N/A
- P/E Ratio
- DCTH N/A
- IFN N/A
- Revenue Growth
- DCTH 945.91
- IFN N/A
- 52 Week Low
- DCTH $3.70
- IFN $14.40
- 52 Week High
- DCTH $16.97
- IFN $21.25
- Technical
- Relative Strength Index (RSI)
- DCTH 46.47
- IFN 36.87
- Support Level
- DCTH $15.50
- IFN $15.66
- Resistance Level
- DCTH $16.43
- IFN $15.91
- Average True Range (ATR)
- DCTH 0.72
- IFN 0.16
- MACD
- DCTH -0.25
- IFN -0.01
- Stochastic Oscillator
- DCTH 2.79
- IFN 7.83
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities and others. Geographically, all the business activity functions through the market of United States.